DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Raedler LA.
Darzalex (daratumumab):First anti-CD38 monoclonal antibody approved for patients with relapsed multiple myeloma.
Am Health Drug Benefits 2016;
9: 70-3
Access:
We do not assume any responsibility for the contents of the web pages of other providers.